"Formerly Asheville Hematology & Oncology - Asheville"

During the past decade, Asheville Hematology-Oncology Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asheville Hematology-Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Asheville Hematology-Oncology Associates" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Asheville Hematology-Oncology Associates" in a lesser frequency.

Most popular intervention types in "Asheville Hematology-Oncology Associates" are "Drug" (13 trials), "Other" (13 trials), "Biological" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (3 trials), "Durvalumab" (2 trials), "Quality-of-Life Assessment" (2 trials) and "Afatinib Dimaleate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asheville Hematology-Oncology Associates" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Asheville Hematology-Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Asheville Hematology-Oncology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asheville Hematology-Oncology Associates, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".